416 



SUBJECT INDEX 



Influenza A virus WS 



hemagglutination 

 NWS substrain and, 26, 27 

 WSM substrain and, 26 



neuropathogenicity transfer 

 KUNZ influenza virus and, 290 

 MEL influenza virus and, 290 

 Oc.I influenza virus and, 290 

 swine 15 influenza virus and, 290 

 WSE influenza virus and, 290 

 WSM influenza virus and, 290 



receptor gradient and, 29 



viral eclipse phase and, 16 

 Influenza A virus WSE 



indicator virus and, 34 



influenza A virus CAM, linkage group 

 interchange and, 285 



influenza A virus MEL 



genetic interaction and, 283, 284-285 

 linkage group interchange and, 285 

 phenotypic mixture and, 286, 294-295 



mouse lung virulence redistribution and, 

 291, 292 



mucoid inhibition and, 37 



neuropathogenicity transfer and, 290 

 Influenza A virus WSM, neuropatho- 

 genicity transfer and, 290 

 Influenza A virus WSN 



influenza A virus MEL 



heterozygosis and, 287-288 

 phenotypic mixture and, 286-287 



influenza A virus Wr, linkage group 

 interchange and, 285 

 Influenza A virus Wr 



influenza A virus WSN, linkage group 

 interchange and, 285 

 Influenza B virus 



autointerference and, 168, 181 



cellular receptors and, 51 



5,6-dichloro-l-/J-D-ribofuranosylbenzi- 

 midazole and, 203, 206-209, 212 



5, 6-diethylbenzimidazole and, 215 



2, 5-dimethylbenzimidazole and, 203, 

 205, 212, 213 



2-ethyl-5-metliylbenzimidazole and, 215 



hemagglutination and, 25 



influenza A virus, pure clone isolations 

 and, 278 



2, 4, 5, 6, 7-pentamethylbenzimidazole 

 and, 215 



receptor gradient and, 29 

 serological variation in, 265 

 urine mucoprotein, hemagglutination 

 inhibition and, 53, 57 

 Influenza B virus GL, 265 

 Influenza B virus LEE, 174, 175, 176, 185, 

 208, 265 

 bovine submaxillary gland mucoprotein 



and, 56 

 fluorescent antibody studies and, 88 

 hemagglutination and, 24, 26 

 indicator virus and, 33, 34 

 mouse lung virulence redistribution and, 



292, 293 

 receptor gradient and, 29 

 stabilized cells, electrophoretic mobility 

 and, 30 

 Influenza B virus MB, 208 

 Influenza B virus MIL 



mouse lung virulence redistribution and, 



292, 293 

 receptor gradient and, 29 

 stabilized cells, electrophoretic mobility 

 and, 30 

 Influenza B virus ROB, mouse lung 



virulence redistribution and, 292 

 Influenza C virus, 254 



cellular receptors and, 51 

 Lifluenza D virus, 254 



cellular receptors and, 51 

 Lifluenza E virus, 254 

 Influenza virus, 15, 83, 103, 113, 183, 200, 

 201, 221, 

 adsorption respiratory cells and, 52 

 antimycin A and, 219 

 Bwaniba virus, interference between, 

 162 

 5, 6-Dichloro-l-a-D-arabinopyranosyl- 

 benzimidazole and, 211, 216 

 eclipse phase and, 16, 18 

 egg-adapted influenza virus WS, inter- 

 ference between, 167, 173 

 elution of, 29 



equine encephalomyelitis virus, inter- 

 ference between, 162, 170-171, 181, 

 184 

 erythrocytes, attachment prevention 



and, 198, 199, 200 

 DL-ethionine and, 217 

 ferret mucosa and, 87 



